Retagliptin Phosphate
| CAS No. | 1256756-88-3 | Cat. No. | BCP23795 |
| Name | Retagliptin Phosphate | ||
| Synonyms | SP-2086; SP 2086; SP2086; | ||
| Formula | C19H21F6N4O7P | M. Wt | 562.36 |
| Description | Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor for treating type-2 diabetes. Retagliptin, also known as SP-2086, is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | DPP | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.